General Information of Drug Off-Target (DOT) (ID: OTU1NS9O)

DOT Name E3 ubiquitin-protein ligase RNF185 (RNF185)
Synonyms EC 2.3.2.27; RING finger protein 185
Gene Name RNF185
Related Disease
Diabetic kidney disease ( )
Systemic lupus erythematosus ( )
Gastric cancer ( )
Stomach cancer ( )
UniProt ID
RN185_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
2.3.2.27
Pfam ID
PF00097
Sequence
MASKGPSASASPENSSAGGPSGSSNGAGESGGQDSTFECNICLDTAKDAVISLCGHLFCW
PCLHQWLETRPNRQVCPVCKAGISRDKVIPLYGRGSTGQQDPREKTPPRPQGQRPEPENR
GGFQGFGFGDGGFQMSFGIGAFPFGIFATAFNINDGRPPPAVPGTPQYVDEQFLSRLFLF
VALVIMFWLLIA
Function
E3 ubiquitin-protein ligase that regulates selective mitochondrial autophagy by mediating 'Lys-63'-linked polyubiquitination of BNIP1. Acts in the endoplasmic reticulum (ER)-associated degradation (ERAD) pathway, which targets misfolded proteins that accumulate in the endoplasmic reticulum (ER) for ubiquitination and subsequent proteasome-mediated degradation. Protects cells from ER stress-induced apoptosis. Responsible for the cotranslational ubiquitination and degradation of CFTR in the ERAD pathway. Also acts as a regulator of the innate antiviral response by catalyzing 'Lys-27'-linked polyubiquitination of CGAS at 'Lys-173' and 'Lys-384', thereby promoting CGAS cyclic GMP-AMP synthase activity. Preferentially associates with the E2 enzymes UBE2J1 and UBE2J2.
Tissue Specificity Ubiquitously expressed.
KEGG Pathway
Protein processing in endoplasmic reticulum (hsa04141 )
Reactome Pathway
Defective CFTR causes cystic fibrosis (R-HSA-5678895 )
ER Quality Control Compartment (ERQC) (R-HSA-901032 )
ABC-family proteins mediated transport (R-HSA-382556 )

Molecular Interaction Atlas (MIA) of This DOT

4 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Diabetic kidney disease DISJMWEY Definitive Genetic Variation [1]
Systemic lupus erythematosus DISI1SZ7 Strong Altered Expression [2]
Gastric cancer DISXGOUK Limited Altered Expression [3]
Stomach cancer DISKIJSX Limited Altered Expression [3]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
7 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of E3 ubiquitin-protein ligase RNF185 (RNF185). [4]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of E3 ubiquitin-protein ligase RNF185 (RNF185). [5]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of E3 ubiquitin-protein ligase RNF185 (RNF185). [6]
Estradiol DMUNTE3 Approved Estradiol affects the expression of E3 ubiquitin-protein ligase RNF185 (RNF185). [7]
Calcitriol DM8ZVJ7 Approved Calcitriol increases the expression of E3 ubiquitin-protein ligase RNF185 (RNF185). [8]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of E3 ubiquitin-protein ligase RNF185 (RNF185). [9]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of E3 ubiquitin-protein ligase RNF185 (RNF185). [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)

References

1 A genome-wide association study for diabetic nephropathy genes in African Americans.Kidney Int. 2011 Mar;79(5):563-72. doi: 10.1038/ki.2010.467. Epub 2010 Dec 8.
2 The E3 ubiquitin ligase RNF185 facilitates the cGAS-mediated innate immune response.PLoS Pathog. 2017 Mar 8;13(3):e1006264. doi: 10.1371/journal.ppat.1006264. eCollection 2017 Mar.
3 RNF185 modulates JWA ubiquitination and promotes gastric cancer metastasis.Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1552-1561. doi: 10.1016/j.bbadis.2018.02.013. Epub 2018 Feb 23.
4 The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
5 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
6 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
7 Identification of novel low-dose bisphenol a targets in human foreskin fibroblast cells derived from hypospadias patients. PLoS One. 2012;7(5):e36711. doi: 10.1371/journal.pone.0036711. Epub 2012 May 4.
8 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
9 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
10 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.